Aardvark Therapeutics Ownership | Who Owns Aardvark Therapeutics?

Aardvark Therapeutics Ownership Summary

Aardvark Therapeutics is owned by 38.80% institutional investors, 24.03% insiders, and 37.17% retail investors. Decheng capital is the largest institutional shareholder, holding 18.06% of AARD shares.

AARD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Aardvark Therapeutics	38.80%	24.03%	37.17%
Sector	Healthcare Stocks	42.53%	10.81%	46.67%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Decheng capital	3.92M	18.06%	$52.06M
Laurion capital management lp	1.05M	4.84%	$13.95M
Vanguard group	555.72K	2.56%	$7.39M
Adage capital partners gp	350.00K	1.61%	$4.65M
Blackrock funding, inc. /de	309.46K	1.43%	$4.11M
Silverarc capital management	306.91K	1.42%	$4.08M
Schonfeld strategic advisors	253.75K	1.17%	$3.37M
Geode capital management	194.03K	0.89%	$2.58M
Cresset asset management	146.78K	0.68%	$1.95M
Cantor fitzgerald, l. p.	96.68K	0.45%	$1.28M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Decheng capital	3.92M	9.08%	$52.06M
Silverarc capital management	306.91K	0.55%	$4.08M
Laurion capital management lp	1.05M	0.24%	$13.95M
Schonfeld strategic advisors	253.75K	0.02%	$3.37M
Cantor fitzgerald, l. p.	96.68K	0.01%	$1.28M
Adage capital partners gp	350.00K	0.01%	$4.65M
Cresset asset management	146.78K	0.01%	$1.95M
Bridgeway capital management	22.00K	0.01%	$292.38K
Stone house investment management	1.00K	0.00%	$13.29K
Two sigma investments, lp	63.57K	0.00%	$844.83K

Top Buyers

Holder	Shares	% Assets	Change
Adage capital partners gp	350.00K	0.01%	175.00K
Cresset asset management	146.78K	0.01%	146.78K
Blackrock funding, inc. /de	309.46K	0.00%	103.67K
Vanguard group	555.72K	0.00%	94.74K
Two sigma investments, lp	63.57K	0.00%	63.57K

Top Sellers

Holder	Shares	% Assets	Change
Cormorant asset management, lp	-	-	-800.19K
Braidwell lp	-	-	-500.00K
Suvretta capital management	-	-	-312.50K
Balyasny asset management	-	-	-35.44K
Schonfeld strategic advisors	253.75K	0.02%	-25.51K

New Positions

Holder	Shares	% Assets	Change	Value
Cresset asset management	146.78K	0.01%	146.78K	$1.95M
Two sigma advisers, lp	25.70K	0.00%	25.70K	$341.55K
Bridgeway capital management	22.00K	0.01%	22.00K	$292.38K
Jane street group	19.45K	-	19.45K	$258.45M
Bank of new york mellon	15.52K	-	15.52K	$206.30K

Sold Out

Holder	Change
Point72 asia (singapore) pte.	-1.28K
Walleye capital	-11.73K
Point72 (difc)	-12.80K
Squarepoint ops	-14.19K
Balyasny asset management	-35.44K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	47	34.29%	8,416,251	-5.60%	38	2.30%	33	10.00%	7	133.33%
Jun 30, 2025	35	29.63%	8,915,797	2.64%	41	0.95%	30	11.11%	3	-
Mar 31, 2025	27	-	8,686,452	-	65	-	27	-	-	-
Jun 30, 2015	1	-	1	-	-	-	1	-	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 15, 2025	Lee Tien-Li	Chief Executive Officer	Buy	$34.80K
Sep 15, 2025	Lee Tien-Li	Chief Executive Officer	Buy	$61.82K
Sep 12, 2025	Lee Tien-Li	Chief Executive Officer	Buy	$42.52K
Sep 11, 2025	Lee Tien-Li	Chief Executive Officer	Buy	$46.93K
Sep 10, 2025	Lee Tien-Li	Chief Executive Officer	Buy	$71.21K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	6	-
2025 Q2	-	-
2007 Q3	1	-
2007 Q1	-	-

AARD Ownership FAQ

Who Owns Aardvark Therapeutics?

Aardvark Therapeutics shareholders are primarily institutional investors at 38.80%, followed by 24.03% insiders and 37.17% retail investors. The average institutional ownership in Aardvark Therapeutics's industry, Biotech Stocks , is 45.24%, which Aardvark Therapeutics falls below.

Who owns the most shares of Aardvark Therapeutics?

Aardvark Therapeutics’s largest shareholders are Decheng capital (3.92M shares, 18.06%), Laurion capital management lp (1.05M shares, 4.84%), and Vanguard group (555.72K shares, 2.56%). Together, they hold 25.46% of Aardvark Therapeutics’s total shares outstanding.

Does Blackrock own Aardvark Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aardvark Therapeutics.

Who is Aardvark Therapeutics’s biggest shareholder by percentage of total assets invested?

Decheng capital is Aardvark Therapeutics’s biggest shareholder by percentage of total assets invested, with 9.08% of its assets in 3.92M Aardvark Therapeutics shares, valued at 52.06M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools